TEAM SHEET “Increasing speed of analysis, obviating bulky consumables, and reducing costs are critical objectives we have pursued in development of our portable flow cytometer, nanostrips, and non-invasive vitals strap. The Nokia Sensing XCHALLENGE provides a unique platform to showcase our efforts.” - Dr. Eugene Chan DMI HEADQUARTERS: Cambridge, Massachusetts, USA TEAM WEBSITE: www.dnamedinstitute.com TEAM LEADER: Dr. Eugene Chan TECHNICAL INNOVATION Currently we are developing our rHEALTH sensor, which is designed to be a universal health sensor with capabilities to assess hundreds of different clinical lab tests in a single drop of blood or bodily fluid. It also features a detachable wireless vitals sensor module for monitoring all vital signs. We recently successfully tested the performance of our technology with NASA on a series of parabolic flights over 160 parabolas and from gravity levels from zero to 1.8 g. We are on track to developing a version of our technology for routine consumer and clinical use. TEAM STORY The DNA Medicine Institute is a medtech incubator, laboratory, and biomedical technology service provider. We specialize in advanced product development, biomedical research, and product development. We bring products to market in a streamlined manner. We have cross-functional expertise in various disciplines of science and engineering. This allows us to identify risks early in biomedical technologies and create executable plans that lead to exciting and marketable products. Our deep expertise in integration is one of our core hallmarks. ABOUT OUR TEAM LEADER Dr. Chan is a physician-innovator who has made numerous contributions to genomic technologies, medical devices, and instrumentation. He is the Founder, President, and CEO of the DNA Medicine Institute, an organization focused on advancing patient care, alleviating human suffering, and treating disease through innovation. Eugene graduated from Harvard University Summa Cum Laude and the Harvard Medical School, MIT HST Program with honors. He completed his internship in internal medicine at Harvard Medical School's Brigham and Women's Hospital and is licensed to practice medicine in multiple states. While taking a six year hiatus from his medical training, he was the Founder, Chairman, and CEO of U.S. Genomics, a company that has completed two commercial DNA analysis instruments based on his principle of single molecule fluorescent DNA scanning. He is the Founder or Co-Founder of various biotechnology and medical devices companies, which in total have raised more than $120 million in funding. He holds more than 50 issued and pending patents. THE NOKIA SENSING XCHALLENGE The $2.25 million global competition to accelerate the development of sensors and sensing technology that is smaller, lighter and able to capture true clinical data on a personalized scale. Making sense of your health. sensing.xprize.org